← All companies

NVS

Novartis AG

NVS NYSE Pharmaceutical Preparations EDGAR ↗

$153.67

-2.48 -1.59%

Key statistics

from XBRL data in SEC filings

Market cap

$293B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$113.48 – $170.46

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 21, 2026 6-K FORM 6-K Jun 11, 2026 6-K Apr 28, 2026 6-K FORM 6-K Mar 18, 2026 6-K Feb 4, 2026 6-K Feb 4, 2026 20-F Feb 4, 2026 6-K FORM 6-K Nov 25, 2025 6-K FORM 6-K Nov 20, 2025 6-K FORM 6-K Nov 5, 2025 6-K Oct 28, 2025 6-K FORM 6-K Oct 27, 2025 6-K FORM 6-K Sep 30, 2025 6-K FORM 6-K Aug 11, 2025 6-K FORM 6-K Jul 17, 2025 6-K Jul 17, 2025 6-K FORM 6-K Jun 2, 2025 6-K Apr 29, 2025 6-K FORM 6-K Apr 3, 2025 6-K FORM 6-K Mar 28, 2025 6-K Jan 31, 2025 6-K Jan 31, 2025 20-F Jan 31, 2025 6-K FORM 6-K Dec 30, 2024 6-K FORM 6-K Nov 25, 2024 6-K FORM 6-K Oct 29, 2024 6-K Oct 29, 2024 6-K FORM 6-K Sep 18, 2024 6-K FORM 6-K Sep 17, 2024 6-K FORM 6-K Aug 8, 2024 6-K Jul 18, 2024 6-K Apr 23, 2024 6-K Jan 31, 2024 6-K Jan 31, 2024 20-F Jan 31, 2024 6-K FORM 6-K Jan 8, 2024 6-K FORM 6-K Dec 11, 2023 6-K FORM 6-K Dec 6, 2023 6-K FORM 6-K Nov 28, 2023 6-K FORM 6-K Oct 30, 2023